CWA Asset Management Group’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-10,300
Closed -$692K – 551
2023
Q4
$692K Buy
+10,300
New +$718K 0.05% 206
2021
Q1
– Sell
-1,115
Closed -$219K – 286
2020
Q4
$219K Buy
+1,115
New +$197K 0.02% 240

Other funds holding MED

CWA Asset Management Group's MED Position: Q1 2024 in Review

CWA Asset Management Group sold out of Medifast (MED) in Q1 2024, closing a stake of 10,300 shares — an estimated $692K sold.

CWA Asset Management Group first reported a position in MED in Q4 2020 and held it in 2 quarters. The position peaked at $692K in Q4 2023. 186 funds tracked by Wall St. Rank hold MED as of Q1 2024.

  • CWA Asset Management Group reported no remaining Medifast position as of Q1 2024 after selling out during the quarter.
  • CWA Asset Management Group sold 10,300 Medifast shares in Q1 2024, an estimated $692K.
  • CWA Asset Management Group first reported a position in Medifast in Q4 2020 and held it in 2 quarters.
  • CWA Asset Management Group's Medifast position peaked at $692K in Q4 2023.
  • 186 funds tracked by Wall St. Rank held Medifast as of Q1 2024.

Based on CWA Asset Management Group's 13F filing for Q1 2024, filed 13 May 2024.